Acrodermatitis chronica atrophicans differential diagnosis: Difference between revisions

Jump to navigation Jump to search
Line 5: Line 5:
==Overview==
==Overview==
==Differentiating [Disease name] from other Diseases==
==Differentiating [Disease name] from other Diseases==
*Based on the main presentation of a [[patient]] with [[acrodermatitis chronica atrophicans]] there are different [[differential diagnosis]]. The following are the most common [[differential diagnosis]] of [[acrodermatitis chronica atrophicans]]:<ref name="pmid33085436">{{cite journal| author=| title=StatPearls | journal= | year= 2021 | volume=  | issue=  | pages=  | pmid=33085436 | doi= | pmc= | url= }} </ref><ref name="pmid20132258">{{cite journal| author=Stanek G, Fingerle V, Hunfeld KP, Jaulhac B, Kaiser R, Krause A | display-authors=etal| title=Lyme borreliosis: clinical case definitions for diagnosis and management in Europe. | journal=Clin Microbiol Infect | year= 2011 | volume= 17 | issue= 1 | pages= 69-79 | pmid=20132258 | doi=10.1111/j.1469-0691.2010.03175.x | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=20132258  }} </ref>
*Based on the main presentation of a [[patient]] with [[acrodermatitis chronica atrophicans]] there are different [[differential diagnosis]]. The following are the most common [[differential diagnosis]] of [[acrodermatitis chronica atrophicans]]:<ref name="pmid33085436">{{cite journal| author=| title=StatPearls | journal= | year= 2021 | volume=  | issue=  | pages=  | pmid=33085436 | doi= | pmc= | url= }} </ref><ref name="pmid20132258">{{cite journal| author=Stanek G, Fingerle V, Hunfeld KP, Jaulhac B, Kaiser R, Krause A | display-authors=etal| title=Lyme borreliosis: clinical case definitions for diagnosis and management in Europe. | journal=Clin Microbiol Infect | year= 2011 | volume= 17 | issue= 1 | pages= 69-79 | pmid=20132258 | doi=10.1111/j.1469-0691.2010.03175.x | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=20132258 }} </ref><ref name="pmid1928618">{{cite journal| author=Aberer E, Klade H, Hobisch G| title=A clinical, histological, and immunohistochemical comparison of acrodermatitis chronica atrophicans and morphea. | journal=Am J Dermatopathol | year= 1991 | volume= 13 | issue= 4 | pages= 334-41 | pmid=1928618 | doi=10.1097/00000372-199108000-00003 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=1928618 }} </ref>
**[[Chronic (medical)|Chronic]] [[venous insufficiency]]
**[[Chronic (medical)|Chronic]] [[venous insufficiency]]
**[[Chronic (medical)|Chronic]] [[Ischemia|arterial insufficiency]]
**[[Chronic (medical)|Chronic]] [[Ischemia|arterial insufficiency]]
Line 11: Line 11:
**[[Frostbite|Cold injury]] ([[Frostbite]])
**[[Frostbite|Cold injury]] ([[Frostbite]])
**[[Livedoid vasculitis]]
**[[Livedoid vasculitis]]
**[[Scleroderma|Localized scleroderma]]
**[[Scleroderma|Localized scleroderma]] (also known as [[morphea]])
**[[Erysipelas]]
**[[Erysipelas]]
**[[Lymphedema]]
**[[Lymphedema]]

Revision as of 13:45, 13 June 2021

Acrodermatitis chronica atrophicans Microchapters

Home

Patient Information

Overview

Historical Perspective

Pathophysiology

Causes

Differentiating Acrodermatitis chronica atrophicans from other Diseases

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Acrodermatitis chronica atrophicans differential diagnosis On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Acrodermatitis chronica atrophicans differential diagnosis

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Acrodermatitis chronica atrophicans differential diagnosis

CDC on Acrodermatitis chronica atrophicans differential diagnosis

Acrodermatitis chronica atrophicans differential diagnosis in the news

Blogs on Acrodermatitis chronica atrophicans differential diagnosis

Directions to Hospitals Treating Type page name here

Risk calculators and risk factors for Acrodermatitis chronica atrophicans differential diagnosis

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Anahita Deylamsalehi, M.D.[2]

Overview

Differentiating [Disease name] from other Diseases

References

  1. "StatPearls". 2021. PMID 33085436 Check |pmid= value (help).
  2. 2.0 2.1 Stanek G, Fingerle V, Hunfeld KP, Jaulhac B, Kaiser R, Krause A; et al. (2011). "Lyme borreliosis: clinical case definitions for diagnosis and management in Europe". Clin Microbiol Infect. 17 (1): 69–79. doi:10.1111/j.1469-0691.2010.03175.x. PMID 20132258.
  3. Aberer E, Klade H, Hobisch G (1991). "A clinical, histological, and immunohistochemical comparison of acrodermatitis chronica atrophicans and morphea". Am J Dermatopathol. 13 (4): 334–41. doi:10.1097/00000372-199108000-00003. PMID 1928618.

Template:WH Template:WS